Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAB3C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | MAP2K4 | FIMM | pan-cancer | AAC | 0.45 | 0.009 |
mRNA | EPAS1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
mRNA | ST6GALNAC2 | CCLE | pan-cancer | AAC | 0.15 | 0.009 |
mRNA | AKAP1 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
mRNA | ERMAP | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
mRNA | DHX30 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | LXN | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
mRNA | GGT6 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
mRNA | JOSD1 | CCLE | pan-cancer | AAC | 0.12 | 0.009 |